Macromolecular pharmaceutical R&D platform

Global Bio-innovative Drug Deployment Strategy

  • 2025

    Novel mRNA technology-based biologic drug treatment options
  • 2030

    Bio-innovative drug combinations
    (mAb和mRNA)Biopharmaceutical Product Launch
  • 2035

    fully integrated multi-therapeutical area, international company eith multi biotechnology platforms
Development of bio-innovative drugs

In the next 15 years, bio-innovative drugs motivate the realization of the whole industry chain capability of large molecule biologics from stock solution to formulation.

Nanjing Headquarter
Drug development and commercialization based on mRNA technology

Cheng Du
Development and manufacturing of monoclonal antibody drugs
Chicago, USA
Global Clinical Research Center
U.S. Marketing
Talk to our researchers about your project

Talk to our researchers about your project

Click to enter
XML 地图 | Sitemap 地图